Dimensional Fund Advisors’s scPharmaceuticals SCPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-33,152
| Closed | -$151K | – | 3359 |
|
2024
Q3 | $151K | Sell |
33,152
-101,928
| -75% | -$465K | ﹤0.01% | 3201 |
|
2024
Q2 | $588K | Sell |
135,080
-31,136
| -19% | -$135K | ﹤0.01% | 3002 |
|
2024
Q1 | $834K | Sell |
166,216
-7,357
| -4% | -$36.9K | ﹤0.01% | 2950 |
|
2023
Q4 | $1.09M | Sell |
173,573
-27,230
| -14% | -$171K | ﹤0.01% | 2917 |
|
2023
Q3 | $1.43M | Sell |
200,803
-6,470
| -3% | -$46.1K | ﹤0.01% | 2848 |
|
2023
Q2 | $2.11M | Hold |
207,273
| – | – | ﹤0.01% | 2770 |
|
2023
Q1 | $1.88M | Sell |
207,273
-7,965
| -4% | -$72.2K | ﹤0.01% | 2756 |
|
2022
Q4 | $1.54K | Buy |
215,238
+76,119
| +55% | +$546 | ﹤0.01% | 2793 |
|
2022
Q3 | $906K | Buy |
139,119
+22,677
| +19% | +$148K | ﹤0.01% | 2905 |
|
2022
Q2 | $561K | Buy |
116,442
+12,908
| +12% | +$62.2K | ﹤0.01% | 3039 |
|
2022
Q1 | $588K | Buy |
103,534
+6,787
| +7% | +$38.5K | ﹤0.01% | 3109 |
|
2021
Q4 | $485K | Buy |
96,747
+17,482
| +22% | +$87.6K | ﹤0.01% | 3173 |
|
2021
Q3 | $527K | Buy |
79,265
+34,438
| +77% | +$229K | ﹤0.01% | 3166 |
|
2021
Q2 | $273K | Sell |
44,827
-2,051
| -4% | -$12.5K | ﹤0.01% | 3278 |
|
2021
Q1 | $311K | Hold |
46,878
| – | – | ﹤0.01% | 3218 |
|
2020
Q4 | $248K | Buy |
46,878
+2,644
| +6% | +$14K | ﹤0.01% | 3199 |
|
2020
Q3 | $330K | Buy |
44,234
+17,884
| +68% | +$133K | ﹤0.01% | 3136 |
|
2020
Q2 | $194K | Buy |
26,350
+10,480
| +66% | +$77.2K | ﹤0.01% | 3213 |
|
2020
Q1 | $117K | Buy |
+15,870
| New | +$117K | ﹤0.01% | 3263 |
|